Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Kiyotsugu Yoshida, Ralph Weichselbaum, Surender Kharbanda & Donald Kufe. (2000) Role for Lyn Tyrosine Kinase as a Regulator of Stress-Activated Protein Kinase Activity in Response to DNA Damage. Molecular and Cellular Biology 20:15, pages 5370-5380.
Read now
Read now
Martin Sattler, Shalini Verma, Christopher H. Byrne, Gautam Shrikhande, Thomas Winkler, Paul A. Algate, Larry R. Rohrschneider & James D. Griffin. (1999) BCR/ABL Directly Inhibits Expression of SHIP, an SH2-Containing Polyinositol-5-Phosphatase Involved in the Regulation of Hematopoiesis. Molecular and Cellular Biology 19:11, pages 7473-7480.
Read now
Read now
Alec W. Gross, Xiaowu Zhang & Ruibao Ren. (1999) Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy. Molecular and Cellular Biology 19:10, pages 6918-6928.
Read now
Read now
Catherine M. Verfaillie, Pankaj Gupta, Felipe Prosper, Randy Hurley, Beverly Lundell & Ravi Bhatia. (1999) Stromal Extracellular Matrix Components As Growth Regulators For Human Hematopoietic Progenitors. Hematology 4:4, pages 321-333.
Read now
Read now
Ren-Yuan Bai, Peter Dieter, Christian Peschel, Stephan W. Morris & Justus Duyster. (1998) Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-γ To Mediate Its Mitogenicity. Molecular and Cellular Biology 18:12, pages 6951-6961.
Read now
Read now
Ravi Bhatia & Catherine M. Verfaillie. (1998) The Effect of Interferon-α on Beta-1 Integrin Mediated Adhesion and Growth Regulation in Chronic Myelogenous Leukemia. Leukemia & Lymphoma 28:3-4, pages 241-254.
Read now
Read now
Hilde Stubdal, Juan Zalvide, Kathryn S. Campbell, Colleen Schweitzer, Thomas M. Roberts & James A. DeCaprio. (1997) Inactivation of pRB-Related Proteins p130 and p107 Mediated by the J Domain of Simian Virus 40 Large T Antigen. Molecular and Cellular Biology 17:9, pages 4979-4990.
Read now
Read now
Eva M. Weissinger, Günther Eissner, Christine Grammer, Susanne Fackler, Burkhard Haefner, Luke S. Yoon, Kimberly S. Lu, Alex Bazarov, John M. Sedivy, Harald Mischak & Walter Kolch. (1997) Inhibition of the Raf-1 Kinase by Cyclic AMP Agonists Causes Apoptosis of v-abl-Transformed Cells. Molecular and Cellular Biology 17:6, pages 3229-3241.
Read now
Read now
Vered Ribon, Susan Hubbell, Roman Herrera & Alan R. Saltiel. (1996) The Product of the cbl Oncogene Forms Stable Complexes In Vivo with Endogenous Crk in a Tyrosine Phosphorylation-Dependent Manner. Molecular and Cellular Biology 16:1, pages 45-52.
Read now
Read now
Articles from other publishers (65)
Geoffrey Brown. (2022) Hematopoietic and Chronic Myeloid Leukemia Stem Cells: Multi-Stability versus Lineage Restriction. International Journal of Molecular Sciences 23:21, pages 13570.
Crossref
Crossref
Xiaoyun Lu, Jeff B. Smaill & Ke Ding. 2020. The Discovery and Utility of Chemical Probes in Target Discovery. The Discovery and Utility of Chemical Probes in Target Discovery
182
213
.
Xiaoyun Lu, Jeff B. Smaill & Ke Ding. (2020) Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations. Journal of Medicinal Chemistry 63:19, pages 10726-10741.
Crossref
Crossref
Itaru Matsumura. 2016. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
29
52
.
Poonam R. Molli, Madhura B. Pradhan, Arvind D. Ingle & Nishigandha R. Naik. (2015) Preclinical model for identification of therapeutic targets for CML offers clues for handling imatinib resistance. Biomedicine & Pharmacotherapy 73, pages 160-170.
Crossref
Crossref
Karen Shires, Iva Shankland, Shaheen Mowla, Samuel Njikan, Jai Jaymacker & Nicolas Novitzky. (2014) Serine and proline-rich ligands enriched via phage-display technology show preferential binding to BCR/ABL expressing cells. Hematology/Oncology and Stem Cell Therapy 7:1, pages 32-40.
Crossref
Crossref
Jian Zheng, Suning Chen, Lan Jiang, Yonghe You, Depei Wu & Yifeng Zhou. (2011) Functional genetic variations of cyclooxygenase-2 and susceptibility to acute myeloid leukemia in a Chinese population. European Journal of Haematology 87:6, pages 486-493.
Crossref
Crossref
Lin Wang, Heather O’Leary & Laura F. Gibson. 2010. Cancer Genome and Tumor Microenvironment. Cancer Genome and Tumor Microenvironment
427
452
.
Tasneem Motiwala, Sarmila Majumder, Kalpana Ghoshal, Huban Kutay, Jharna Datta, Satavisha Roy, David M. Lucas & Samson T. Jacob. (2009) PTPROt Inactivates the Oncogenic Fusion Protein BCR/ABL and Suppresses Transformation of K562 Cells. Journal of Biological Chemistry 284:1, pages 455-464.
Crossref
Crossref
S Sahay, N L Pannucci, G M Mahon, P L Rodriguez, N J Megjugorac, E V Kostenko, H L Ozer & I P Whitehead. (2007) The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation. Oncogene 27:14, pages 2064-2071.
Crossref
Crossref
N. Underhill-Day, A. Pierce, S. E. Thompson, D. Xenaki, A. D. Whetton & P. J. Owen-Lynch. (2006) Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. British Journal of Haematology 132:6, pages 774-783.
Crossref
Crossref
Keith Quincy Tanis & Martin Alexander Schwartz. 2006. Abl Family Kinases in Development and Disease. Abl Family Kinases in Development and Disease
16
25
.
B Clarkson, A Strife, D Wisniewski, C L Lambek & C Liu. (2003) Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia 17:7, pages 1211-1262.
Crossref
Crossref
Dieter Kirchner, Justus Duyster, Oliver Ottmann, Roland M. Schmid, Lothar Bergmann & Gerd Munzert. (2003) Mechanisms of Bcr-Abl-mediated NF-κB/Rel activation. Experimental Hematology 31:6, pages 504-511.
Crossref
Crossref
Elena G. ChioreanScott J. DyllaKrista OlsenTodd LenvikYvette SoignierJeffrey S. Miller. (2003) BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs). Blood 101:9, pages 3527-3533.
Crossref
Crossref
David Warren, Deborah S. Griffin, Celine Mainville & Naomi Rosenberg. (2003) The Extreme Carboxyl Terminus of v-Abl Is Required for Lymphoid Cell Transformation by Abelson Virus. Journal of Virology 77:8, pages 4617-4625.
Crossref
Crossref
Ramadevi Nimmanapalli & Kapil Bhalla. (2002) Novel targeted therapies for Bcr–Abl positive acute leukemias: beyond STI571. Oncogene 21:56, pages 8584-8590.
Crossref
Crossref
Kiyotsugu Yoshida, Yoshio Miki & Donald Kufe. (2002) Activation of SAPK/JNK Signaling by Protein Kinase Cδ in Response to DNA Damage. Journal of Biological Chemistry 277:50, pages 48372-48378.
Crossref
Crossref
Francis J. Giles, Hagop M. Kantarjian, B. Nebiyou Bekele, Jorge E. Cortes, Stephan Faderl, Deborah A. Thomas, Taghi Manshouri, Anna Rogers, Michael J. Keating, Moshe Talpaz, Susan O'Brien & Maher Albitar. (2002) Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival. British Journal of Haematology 119:1, pages 38-45.
Crossref
Crossref
Keding Cheng, Razelle Kurzrock, Xiangguo Qiu, Zeev Estrov, Stella Ku, Kim M. Dulski, Jean Y. J. Wang & Moshe Talpaz. (2002) Reduced focal adhesion kinase and paxillin phosphorylation in BCR-ABL-transfected cells. Cancer 95:2, pages 440-450.
Crossref
Crossref
Hikaru Nakajima, Robert Zhao, Troy C. Lund, Jeanne Ward, Michelle Dolan, Betsy Hirsch & Jeffrey S. Miller. (2002)
The
BCR/ABL
Transgene Causes Abnormal NK Cell Differentiation and Can Be Found in Circulating NK Cells of Advanced Phase Chronic Myelogenous Leukemia Patients
. The Journal of Immunology 168:2, pages 643-650.
Crossref
Crossref
Helma Pluk, Karel Dorey & Giulio Superti-Furga. (2002) Autoinhibition of c-Abl. Cell 108:2, pages 247-259.
Crossref
Crossref
Yinxiang Wang, Ann L. Miller, Mark S. Mooseker & Anthony J. Koleske. (2001) The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin. Proceedings of the National Academy of Sciences 98:26, pages 14865-14870.
Crossref
Crossref
Pamela J. Woodring, Tony Hunter & Jean Y.J. Wang. (2001) Inhibition of c-Abl Tyrosine Kinase Activity by Filamentous Actin. Journal of Biological Chemistry 276:29, pages 27104-27110.
Crossref
Crossref
Balkrishna N Jahagirdar, Jeffrey S Miller, Arun Shet & Catherine M Verfaillie. (2001) Novel therapies for chronic myelogenous leukemia. Experimental Hematology 29:5, pages 543-556.
Crossref
Crossref
Robert C. ZhaoYuehua JiangCatherine M. Verfaillie. (2001) A model of human p210bcr/ABL-mediated chronic myelogenous leukemia by transduction of primary normal human CD34+ cells with a BCR/ABL-containing retroviral vector. Blood 97:8, pages 2406-2412.
Crossref
Crossref
Paolo Vigneri & Jean Y. J. Wang. (2001) Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase. Nature Medicine 7:2, pages 228-234.
Crossref
Crossref
A Krämer, H Löffler, J Bergmann, A Hochhaus & R Hehlmann. (2001) Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia. Leukemia 15:1, pages 62-68.
Crossref
Crossref
Jean YJ Wang. (2000) Regulation of cell death by the Abl tyrosine kinase. Oncogene 19:49, pages 5643-5650.
Crossref
Crossref
Sunita CoutinhoThomas JahnMarc LewitzkyStephan FellerPeter HutzlerChristian PeschelJustus Duyster. (2000) Characterization of Grb4, an adapter protein interacting with Bcr-Abl. Blood 96:2, pages 618-624.
Crossref
Crossref
Sunita CoutinhoThomas JahnMarc LewitzkyStephan FellerPeter HutzlerChristian PeschelJustus Duyster. (2000) Characterization of Grb4, an adapter protein interacting with Bcr-Abl. Blood 96:2, pages 618-624.
Crossref
Crossref
Weidong Xu, Konstantina Angelis, David Danielpour, Maher M. Haddad, Oliver Bischof, Judith Campisi, Ed Stavnezer & Estela E. Medrano. (2000) Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type β transforming growth factor. Proceedings of the National Academy of Sciences 97:11, pages 5924-5929.
Crossref
Crossref
David Warren, Andrew J. Heilpern, Kent Berg & Naomi Rosenberg. (2000) The Carboxyl Terminus of v-Abl Protein Can Augment SH2 Domain Function. Journal of Virology 74:10, pages 4495-4504.
Crossref
Crossref
Isabelle Gaston, Paula E. Stenberg, Arun Bhat & Brian J. Druker. (2000) Abl kinase but not PI3-kinase links to the cytoskeletal defects in Bcr-Abl transformed cells. Experimental Hematology 28:1, pages 77-86.
Crossref
Crossref
Saghi Ghaffari, Florence Smadja-Joffe, Robert Oostendorp, Jean-Pierre Lévesque, Graeme Dougherty, Allen Eaves & Connie Eaves. (1999) CD44 isoforms in normal and leukemic hematopoiesis. Experimental Hematology 27:6, pages 978-993.
Crossref
Crossref
Richard C Frank, Xiao Sun, Francisco J Berguido, Andrzej Jakubowiak & Stephen D Nimer. (1999) The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1. Oncogene 18:9, pages 1701-1710.
Crossref
Crossref
Alwin Krämer, Susanne Hörner, Andreas Willer, Stefan Fruehauf, Andreas Hochhaus, Michael Hallek & Rüdiger Hehlmann. (1999)
Adhesion to fibronectin stimulates proliferation of wild-type and
bcr/abl
-transfected murine hematopoietic cells
. Proceedings of the National Academy of Sciences 96:5, pages 2087-2092.
Crossref
Crossref
Paris A Skourides, Samanthi A Perera & Ruibao Ren. (1999) Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins. Oncogene 18:5, pages 1165-1176.
Crossref
Crossref
Xiaowu ZhangRuibao Ren. (1998) Bcr-Abl Efficiently Induces a Myeloproliferative Disease and Production of Excess Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor in Mice: A Novel Model for Chronic Myelogenous Leukemia. Blood 92:10, pages 3829-3840.
Crossref
Crossref
Xiaowu ZhangRuibao Ren. (1998) Bcr-Abl Efficiently Induces a Myeloproliferative Disease and Production of Excess Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor in Mice: A Novel Model for Chronic Myelogenous Leukemia. Blood 92:10, pages 3829-3840.
Crossref
Crossref
Rene Daniel, Siu-Wah Chung, Hong Chen & Peter M. C. Wong. (1998) Retroviral transfer of antisense sequences results in reduction of c-Abl and induction of apoptosis in hemopoietic cells. Journal of Biomedical Science 5:5, pages 383-394.
Crossref
Crossref
Ying Zhang, Xin-Hua Feng & Rik Derynck. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394:6696, pages 909-913.
Crossref
Crossref
Frederic G. Barr. (1998) Translocations, cancer and the puzzle of specificity. Nature Genetics 19:2, pages 121-124.
Crossref
Crossref
Ravi BhatiaCatherine M. Verfaillie. (1998) Inhibition of BCR-ABL Expression With Antisense Oligodeoxynucleotides Restores β1 Integrin-Mediated Adhesion and Proliferation Inhibition in Chronic Myelogenous Leukemia Hematopoietic Progenitors. Blood 91:9, pages 3414-3422.
Crossref
Crossref
Ravi BhatiaCatherine M. Verfaillie. (1998) Inhibition of BCR-ABL Expression With Antisense Oligodeoxynucleotides Restores β1 Integrin-Mediated Adhesion and Proliferation Inhibition in Chronic Myelogenous Leukemia Hematopoietic Progenitors. Blood 91:9, pages 3414-3422.
Crossref
Crossref
Micheline Giphart-Gassler, Arnolda De Nooij-Van Dalen, Vera Van Buuren-Van Seggelen, Bruno Morolli, Paul Lohman & Hanneke Kluin-Nelemans. (1998) A search for novel tumour suppressor genes for adult acute leukaemia by allelotyping at sub-telomeric chromosomal regions. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 400:1-2, pages 409-419.
Crossref
Crossref
Daniela Barilá & Giulio Superti-Furga. (1998) An intramolecular SH3-domain interaction regulates c-Abl activity. Nature Genetics 18:3, pages 280-282.
Crossref
Crossref
Catherine M. Verfaillie. (1998) BIOLOGY OF CHRONIC MYELOGENOUS LEUKEMIA. Hematology/Oncology Clinics of North America 12:1, pages 1-29.
Crossref
Crossref
Catherine M. Verfaillie, Ravi Bhatia, Paul Browne & Nigel S. Key. (1998) Interferon-α restores β1-integrin-dependent, collagen-mediated platelet aggregation in a patient with chronic myelogenous leukemia. Journal of Laboratory and Clinical Medicine 131:2, pages 163-169.
Crossref
Crossref
Kermit L. Carraway, Coralie A. Carothers Carraway & Kermit L. CarrawayIIIIIIKermit L. Carraway, Coralie A. Carothers Carraway & Kermit L. CarrawayIIIIII. 1998. Signaling and the Cytoskeleton. Signaling and the Cytoskeleton
243
263
.
Robert C.H. ZhaoR. Scott McIvorJames D. GriffinCatherine M. Verfaillie. (1997) Gene Therapy for Chronic Myelogenous Leukemia (CML): A Retroviral Vector That Renders Hematopoietic Progenitors Methotrexate-Resistant and CML Progenitors Functionally Normal and Nontumorigenic In Vivo. Blood 90:12, pages 4687-4698.
Crossref
Crossref
Robert C.H. ZhaoR. Scott McIvorJames D. GriffinCatherine M. Verfaillie. (1997) Gene Therapy for Chronic Myelogenous Leukemia (CML): A Retroviral Vector That Renders Hematopoietic Progenitors Methotrexate-Resistant and CML Progenitors Functionally Normal and Nontumorigenic In Vivo. Blood 90:12, pages 4687-4698.
Crossref
Crossref
Catherine M. Verfaillie. (1997) STEM CELLS IN CHRONIC MYELOGENOUS LEUKEMIA. Hematology/Oncology Clinics of North America 11:6, pages 1079-1114.
Crossref
Crossref
Martin Alexander Schwartz. (1997) Integrins, Oncogenes, and Anchorage Independence. Journal of Cell Biology 139:3, pages 575-578.
Crossref
Crossref
Martin Sattler & Ravi Salgia. (1997) Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine & Growth Factor Reviews 8:1, pages 63-79.
Crossref
Crossref
N Tavoloni & H Inoue. (1997) Cellular aging is a critical determinant of primary cell resistance to v-src transformation. Journal of Virology 71:1, pages 237-247.
Crossref
Crossref
Tetsuzo Tauchi, Keisuke Miyazawa, Gen-Sheng Feng, Hal E. Broxmeyer & Keisuke Toyama. (1997) A Coiled-coil Tetramerization Domain of BCR-ABL Is Essential for the Interactions of SH2-containing Signal Transduction Molecules. Journal of Biological Chemistry 272:2, pages 1389-1394.
Crossref
Crossref
Richard K Assoian & Xiaoyun Zhu. (1997) Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Current Opinion in Cell Biology 9:1, pages 93-98.
Crossref
Crossref
Jean M. Lewis, Rajasekaran Baskaran, Salme Taagepera, Martin A. Schwartz & Jean Y. J. Wang. (1996) Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic–nuclear transport. Proceedings of the National Academy of Sciences 93:26, pages 15174-15179.
Crossref
Crossref
G. D. Telegeev, M. V. Dybkov, M. V. Bozhko, N. M. Tretiak & S. S. Maliuta. (1996) Molecular-biology approaches to detection of Philadelphia chromosome in patients with leukemia. Biopolymers and Cell 12:6, pages 63-68.
Crossref
Crossref
Yan Chen, Jean-Jacques Lebrun & Wylie Vale. (1996) Regulation of transforming growth factor β- and activin-induced transcription by mammalian Mad proteins. Proceedings of the National Academy of Sciences 93:23, pages 12992-12997.
Crossref
Crossref
Yan Chen, Erik S. Knudsen & Jean Y.J. Wang. (1996) Cells Arrested in G1 by the v-Abl Tyrosine Kinase Do Not Express Cyclin A Despite the Hyperphosphorylation of RB. Journal of Biological Chemistry 271:33, pages 19637-19640.
Crossref
Crossref
Mark W. Renshaw, Elaine Lea-Chou & Jean Y.J. Wang. (1996) Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Current Biology 6:1, pages 76-83.
Crossref
Crossref
Caroline A. Evans & Andrew Pierce. 1996. Blood Cell Biochemistry. Blood Cell Biochemistry
99
120
.
Ravi Salgia, Naoki Uemura, Keiko Okuda, Jian-Liang Li, Evan Pisick, Martin Sattler, Ron de Jong, Brian Druker, Nora Heisterkamp, Lan Bo Chen, John Groffen & James D. Griffin. (1995) CRKL Links p210BCR/ABL with Paxillin in Chronic Myelogenous Leukemia Cells. Journal of Biological Chemistry 270:49, pages 29145-29150.
Crossref
Crossref